Phan Dillon
Directeur Technique/Scientifique/R&D chez IBIO, INC.
Profil
Phan Dillon is currently the Vice President, Head-Research & Development at iBio, Inc. Previously, Dr. Dillon worked as the Director-In Vivo Pharmacology at Ferring Pharmaceuticals, Inc. and as the Associate Director-Drug Discovery at Pelican Inc. Dr. Dillon holds undergraduate and doctorate degrees from the University of California, Davis and a doctorate degree from The University of Texas at Austin.
Postes actifs de Phan Dillon
| Sociétés | Poste | Début |
|---|---|---|
| IBIO, INC. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Phan Dillon
| Sociétés | Poste | Fin |
|---|---|---|
| PFENEX INC. | Corporate Officer/Principal | - |
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | - |
Formation de Phan Dillon
| The University of Texas at Austin | Doctorate Degree |
| University of California, Davis | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IBIO, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Health Technology |
Pelican Inc
 Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
